New hypertension guidelines - Need for action for general practitioners?;Neue bluthochdruck-leitlinien - Handlungsbedarf für hausärzte?

Zeitschrift fur Allgemeinmedizin

Volumn 80, Issue 6, 2004, Pages 237-242

  Vollmar, Horst Christian ^a   Rieger, M A ^a   Popert, U ^b   Butzlaff, M ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Combination therapy; First line therapy; Guidelines; Hypertension; Thresholds

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE; CLINICAL EXAMINATION; DISEASE CONTROL; DRUG CHOICE; GERMANY; HUMAN; HYPERTENSION; LIFESTYLE; NORMAL VALUE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SMOKING CESSATION; WEIGHT REDUCTION;

EID: 3042734118     PISSN: 09376801     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Jama 2002; 288: 2981-2997
2. AWMF, Deutsche Hypertonie Gesellschaft (Hochdruckliga). Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie. 2001/2003
3. Blech J. Die Krankmacher - wie Ärzte und Pharma-Industrie neue Krankheiten erfinden. Der Spiegel 2003; 33
4. Boersma E, Keil U, De Bacquer D et al. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens 2003; 21: 1831-1840
5. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. Jama 2003; 289: 2560-2571
6. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601-1610
7. European Society of Hypertension (ESH), European Society of Cardiology (ESC). Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053
8. Geleijnse JM, Witteman JC, Bak AA, den Breeijen JH, Grobbee DE. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Bmj 1994; 309: 436-440
9. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762
10. lskedjian M, Einarson TR, MacKeigan LD et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 2002; 24: 302-316
11. National Institute of Health (NIH). The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446
12. Kaiser T, Florack C, Stephan U, Sawicki PT. Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy. Br J Diabetes Vasc Dis 2003; 3: 278-281
13. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002; 324: 1570-1576
14. Medizinisches Wissensnetzwerk evidence.de der Universität Witten/Herdecke 2003. Vollmar HC, Koneczny N, Butzlaff M, Isfort J. Leitlinie Hypertonie 2003.
15. Mulrow CD, Chiquette E, Angel L et al. Dieting to reduce body weight for controlling hypertension in adults (Cochrane Review). The Cochrane Library, Vol 2, John Wiley, Chichester, 2004
16. Pastor-Barriuso R, Banegas JR, Damian J, Appel LJ, Guallar E. Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med 2003; 139: 731-739
17. Port S, Demer L, Jennrich R, Walter D, Garfinkel A. Systolic blood pressure and mortality. Lancet 2000; 355: 175-180
18. Prospective Studies Collaboration. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913
19. Psaty BM, Lumley T, Furberg CD et al. Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents: A Network Meta-analysis. Jama 2003; 289: 2534-2544
20. Thamm M. Blutdruck in Deutschland - Zustandsbeschreibungen und Trends. Gesundheitswesen 1999; 61 (Sonderheft 2): S90-S93
21. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-1686
22. World Health Organization - International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-185
23. Wing LM, Reid CM, Ryan P et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-592
24. Wolf-Maier K, Cooper RS, Banegas JR et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. Jama 2003; 289: 2363-2369
25. Zidek W, Dusing R, Haller H, Middeke M, Paul M, Schmieder R, Schrader J. [New recommendations of the German Society of Hypertension for the drug treatment of hypertension]. Dtsch Med Wochenschr 2003; 128: 2468-2469
26. Lawes CM, Bennett DA, Feigin VL, et al. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 776-785
27. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297
28. Williams B, Poulter NR, Brown MJ et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. Bmj 2004; 328: 634-640
29. Schrier RW, Estacio RO, Esler A et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61: 1086-1097
30. Ogden LG, He J, Lydick E et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNCVI risk stratification. Hypertension 2000; 35: 539-543
31. N N. arznei-telegramm 2003; 34: 97-98